Biomarkers · Cardiometabolic

Metabolic Syndrome (Harmonized Definition)

Lower values go with lower risk of death. No risk curve catalogued yet.

Published risk of death1.46×metabolic syndrome present vs absent (95% CI 1.35–1.57) · Meta-analysis of 21 prospective cohort studies (372,411 participants), general population

Sources

Wu et al. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. European journal of epidemiology. 2010;25:375-84.

Related markers: Apolipoprotein B to A1 Ratio (ApoB/ApoA1) · Asymmetric Dimethylarginine (ADMA) · Homoarginine · Lipid Accumulation Product (LAP) · Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) · Non-HDL Cholesterol · Trimethylamine N-oxide (TMAO)